MedTrace Logo

Effect of Pharmacists Treating Diabetes in a FQHC

NCT03134170 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 239

Last updated 2018-11-16

No results posted yet for this study

Summary

This study is a randomized controlled cross-over trial, in the form of a proof of concept study that is designed to evaluate the health outcomes resulting from incorporating a licensed clinical pharmacist in a health care team to provide case management for diabetic patients at the Henry J Austin Health Clinic. The study uses a control group design and will feature both an experimental group and a control group. The control group, of 80 patients, will receive the standard treatment at the clinic. The experimental group, of 80 patients, will receive the standard treatment as well as Medication Therapy Management and counseling from a pharmacist. After one year the patients in the control group can cross-over to the intervention group and receive care from the pharmacist.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Pharmacist review of therapy

Patients who are randomized to the pharmacist group will have their treatment reviewed by a pharmacist

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Caitlin McCarthy, PharmD · Rutgers, Earnest Mario School of Pharmacy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-01
Primary Completion
2018-11-01
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03134170 on ClinicalTrials.gov